Red Reef Laboratories Forcasts $15 to $25 Million Revenues
Red Reef Laboratories International, Inc, (Pink Sheets: RRLB) today forcasted potential revenues for its wholly owned subsidiary, MyoTrend Nutritional Technologies at between $15 and $25 Million as a result of recent international distribution relationships. Recent collaborations offer a 50 country distribution channel into 1,200 outlets. According to the company’s collaborative partners, 80% of its revenues occur in 12 of these countries. The figures are based upon a percentage of revenues currently being experienced by the company’s collaborative partners.
In a related development, the company also revealed that they will be utilizing their MyoFit Fitness Journal, the company’s fitness publication, as a vehicle for tying in their new collaborative partner’s products with the MyoTrend brand. The plan has proven to resonate well with distributors worldwide, as demonstrated by recently announced distribution agreements, largely due to tie-ins with MyoFit Magazine.
While we acknowledge that these lofty numbers may cause some to raise their eyebrows in disbelief, we also note that, if the company only accomplishes half of it’s forcasted potential or delivers at the low side of the projections, the numbers will still demonstrate a successful company with very impressive numbers. If the company is able to deliver even $.002 in annual earnings per share, current shareholders will have something to brag about at cocktails and family reunions. At a rational 30 times earnings, this could turn this sub-penny stock into a stock trading at $.06 and could turn a $350 investment into $6,000.
We continue to follow Red Reef Laboratories progress with optimism and great interest. For more information on RRLB, click here.
Note: We have been hired by an independent third party to feature RRLB on our Real Stock Discoveries website for the month of October. That includes coverage here as well. For more information please visit our disclaimer.
